Company Filing History:
Years Active: 2014-2022
Title: Nicole Haubst: Innovator in Antibody Research
Introduction
Nicole Haubst is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 9 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
Among her latest patents, Nicole has developed anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules. This patent provides anti-BTC antibodies, methods of producing these antibodies, pharmaceutical compositions comprising these antibodies, and methods of using them. Additionally, she has worked on thymic stromal lymphopoietin (TSLP)-binding molecules, which include antibodies or antibody fragments that specifically bind TSLP, along with compositions and methods for their use and production.
Career Highlights
Nicole Haubst is currently employed at Novartis AG, a leading global healthcare company. Her role involves extensive research and development in the field of antibody therapies, where she applies her expertise to create innovative solutions for medical challenges.
Collaborations
Throughout her career, Nicole has collaborated with notable colleagues, including Seth Alexander Ettenberg and Andrew Paul Garner. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Nicole Haubst is a trailblazer in the field of antibody research, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to advance the understanding and application of therapeutic antibodies in medicine.